Journal of Reproductive Immunology
Volume 85, Issue 1 , Pages 25-32 , May 2010

Recurrent miscarriage: current concepts in diagnosis and treatment

  • Bettina Toth

      Affiliations

    • Department of Gynecological Endocrinology and Fertility Disorders, Ruprecht-Karl University Heidelberg, Voßstr. 9, 69115 Heidelberg, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 6221 56 7921; fax: +49 6221 56 4009.
    • ,
  • Udo Jeschke

      Affiliations

    • Department of Obstetrics and Gynecology - Maistrasse, Ludwig-Maximilians-University, 80377 Munich, Germany
    • Tel.: +49 89 5160 4266; fax: +49 89 5160 4916.
    • ,
  • Nina Rogenhofer

      Affiliations

    • Department of Obstetrics and Gynecology - Großhadern, Ludwig-Maximilians-University, 81377 Munich, Germany
    • Tel.: +49 89 7095 6825; fax: +49 89 7095 3844.
    • ,
  • Christoph Scholz

      Affiliations

    • Department of Obstetrics and Gynecology - Maistrasse, Ludwig-Maximilians-University, 80377 Munich, Germany
    • Tel.: +49 89 5160 4266; fax: +49 89 5160 4916.
    • ,
  • Wolfgang Würfel

      Affiliations

    • Kinderwunsch Centrum München/Tagesklinik, Lortzingstr. 26, 81241 München, Germany
    • Tel.: +49 89 24414 40; fax: +49 89 244144 41.
    • ,
  • Christian J. Thaler

      Affiliations

    • Department of Obstetrics and Gynecology - Großhadern, Ludwig-Maximilians-University, 81377 Munich, Germany
    • Tel.: +49 89 7095 6825; fax: +49 89 7095 3844.
    • ,
  • Antonis Makrigiannakis

      Affiliations

    • Department of Obstetrics and Gynaecology, Medical School, University of Crete, Heraklion 71003, Greece
    • Tel.: +30 2810392131; fax: +30 2810392131.

Received 12 August 2009 ,Revised 1 December 2009 ,Accepted 13 December 2009.

References 

  1. Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid. 2002;12:63–68
  2. Ashkar AA, Di Santo JP, Croy BA. Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J. Exp. Med. 2000;192:259–270
  3. Bane AL, Gillan JE. Massive perivillous fibrinoid causing recurrent placental failure. BJOG. 2003;110:292–295
  4. Brenner B. Haemostatic changes in pregnancy. Thromb. Res. 2004;114:409–414
  5. Brenner B. Thrombophilia and pregnancy loss in first intended pregnancy. J. Thromb. Haemost. 2005;3:2176–2177
  6. Bretelle F, Sabatier F, Desprez D, Camoin L, Grunebaum L, Combes V, et al. Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction. Thromb. Haemost. 2003;89:486–492
  7. Bulla R, Bossi F, Radillo O, De Seta F, Tedesco F. Placental trophoblast and endothelial cells as target of maternal immune response. Autoimmunity. 2003;36:11–18
  8. Cabrero A, Cubero M, Llaverias G, Alegret M, Sanchez R, Laguna JC, et al. Leptin down-regulates peroxisome proliferator-activated receptor gamma (PPAR-gamma) mRNA levels in primary human monocyte-derived macrophages. Mol. Cell. Biochem. 2005;275:173–179
  9. Carp H, Dardik R, Lubetsky A, Salomon O, Eskaraev R, Rosenthal E, et al. Prevalence of circulating procoagulant microparticles in women with recurrent miscarriage: a case-controlled study. Hum. Reprod. 2004;19:191–195
  10. Carrington B, Sacks G, Regan L. Recurrent miscarriage: pathophysiology and outcome. Curr. Opin. Obstet. Gynecol. 2005;17:591–597
  11. Christiansen OB, Pedersen B, Rosgaard A, Husth M. A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage. Hum. Reprod. 2002;17:809–816
  12. Christiansen OB, Steffensen R, Nielsen HS, Varming K. Multifactorial etiology of recurrent miscarriage and its scientific and clinical implications. Gynecol. Obstet. Invest. 2008;66:257–267
  13. Clark DA, Coulam CB, Daya S, Chaouat G. Unexplained sporadic and recurrent miscarrage in the new millennium: a critical analysis of immune mechanisms and treatments. Hum. Reprod. Update. 2001;7:501–511
  14. Clifford K, Rai R, Regan L. Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum. Reprod. 1997;12:387–389
  15. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil. Steril. 2008;89:505–522
  16. Dell A, Morris HR, Easton RL, Panico M, Patankar M, Oehniger S, et al. Structural analysis of the oligosaccharides derived from glycodelin, a human glycoprotein with potent immunosuppressive and contraceptive activities. J. Biol. Chem. 1995;270:24116–24126
  17. Dolitzky M, Inbal A, Segal Y, Weiss A, Brenner B, Carp H. A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. Fertil. Steril. 2006;86:362–366
  18. Ernst P, Bacigalupo A, Ringden O, Ruutu T, Kolb HJ, Lawrinson S, et al. A phase 3, randomized, placebo-controlled trial of filgrastim in patients with haematological malignancies undergoing matched-related allogeneic bone marrow transplantation. Arch. Drug Inf. 2008;1:89–96
  19. Faridi RM, Das V, Tripthi G, Talwar S, Parveen F, Agrawal S. Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages. Hum. Reprod. 2009;24:1758–1764
  20. Fertl KI, Bergner A, Beyer R, Klapp BF, Rauchfuss M. Levels and effects of different forms of anxiety during pregnancy after a prior miscarriage. Eur. J. Obstet. Gynecol. Reprod. Biol. 2009;142:23–29
  21. Fournier T, Tsatsaris V, Handschuh K, Evain-Brion D. PPARs and the placenta. Placenta. 2007;28:65–76
  22. Franssen MT, Korevaar JC, Leschot NJ, Bossuyt PM, Knegt AC, Gerssen-Schoorl KB, et al. Selective chromosome analysis in couples with two or more miscarriages: case–control study. BMJ. 2005;331:137–141
  23. Gharesi-Fard B, Zolghadri J, Kamali-Sarvestani E. Effect of leukocyte therapy on tumor necrosis factor-alpha and interferon-gamma production in patients with recurrent spontaneous abortion. Am. J. Reprod. Immunol. 2008;59:242–250
  24. Ghosh K, Shetty S, Vora S, Salvi V. Successful pregnancy outcome in women with bad obstetric history and recurrent fetal loss due to thrombophilia: effect of unfractionated heparin and low-molecular weight heparin. Clin. Appl. Thromb. Hemost. 2008;14:174–179
  25. Gonzalez-Quintero VH, Smarkusky LP, Jimenez JJ, Mauro LM, Jy W, Hortsman LL, et al. Elevated plasma endothelial microparticles: preeclampsia versus gestational hypertension. Am. J. Obstet. Gynecol. 2004;191:1418–1424
  26. Henson MC, Swan KF, O’neil JS. Expression of placental leptin and leptin receptor transcripts in early pregnancy and at term. Obstet. Gynecol. 1998;92:1020–1028
  27. Hiby SE, Regan L, Lo W, Farrell L, Carrington M, Moffett A. Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum. Reprod. 2008;23:972–976
  28. Hirahara F, Andoh N, Sawai K, Hirabuki T, Uemura T, Minaguchi H. Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials. Fertil. Steril. 1998;70:246–252
  29. Homburg R. Pregnancy complications in PCOS. Best Pract. Res. Clin. Endocrinol. Metab. 2006;20:281–292
  30. Homburg R. Polycystic ovary syndrome. Best Pract. Res. Clin. Obstet. Gynaecol. 2008;22(2):261–274Epub 2007 Sep 5. Review
  31. Homer HA, Li TC, Cooke ID. The septate uterus: a review of management and reproductive outcome. Fertil. Steril. 2000;73:1–14
  32. Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2002;87:524–529
  33. Jauniaux E, Farquharson RG, Christiansen OB, Exalto N. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum. Reprod. 2006;21:2216–2222
  34. Jeschke U, Briese V, Richter D, Kunkel S. Stimulation trials of trophoblast cells in vitro using PP14. Z. Geburtshilfe Neonatol. 1996;200:199–201
  35. Jeschke U, Briese V, Richter D, Kunkel S, Walzel H, Friese K. Neue Ergebnisse zur hCG-regulation in der plazenta. Geburtshilfe Frauenheilkd. 1997;57:681–684
  36. Jeschke U, Karsten U, Reimer T, Richter DU, Bergemann C, Briese V, et al. Stimulation of hCG protein and mRNA in first trimester villous cytotrophoblast cells in vitro by glycodelin A. J. Perinat. Med. 2005;33:212–218
  37. Jeschke U, Richter DU, Walzel H, Bergemann C, Mylonas I, Sharma S, et al. Stimulation of hCG and inhibition of hPL in isolated human trophoblast cells in vitro by glycodelin A. Arch. Gynecol. Obstet. 2003;268:162–167
  38. Jeschke U, Stahn R, Goletz C, Wang X, Briese V, Friese K. hCG in trophoblast tumour cells of the cell line Jeg3 and hCG isolated from amniotic fluid and serum of pregnant women carry oligosaccharides of the sialyl Lewis X and sialyl Lewis a type. Anticancer Res. 2003;23:1087–1092
  39. Lappas M, Permezel M, Rice GE. Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-kappaB, peroxisomal proliferator-activated receptor-gamma and extracellularly regulated kinase 1/2. Endocrinology. 2005;146:3334–3342
  40. Laskin CA, Spitzer KA, Clark CA, Crowther MR, Ginsberg JS, Hawker GA, et al. Low molecular Weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA trial. J. Rheumatol. 2009;36(2):279–287
  41. Laude I, Rongieres-Bertrand C, Boyer-Neumann C, Wolf M, Mairovitz V, Hugel B, et al. Circulating procoagulant microparticles in women with unexplained pregnancy loss: a new insight. Thromb. Haemost. 2001;85:18–21
  42. Laurino MY, Bennett RL, Saraiya DS, Baumeister L, Doyle DL, Leppig K, et al. Genetic evaluation and counseling of couples with recurrent miscarriage: recommendations of the National Society of Genetic Counselors. J. Genet. Couns. 2005;14:165–181
  43. Leong H, Stachnik J, Bonk ME, Matuszewski KA. Unlabeled uses of intravenous immune globulin. Am. J. Health Syst. Pharm. 2008;65:1815–1824
  44. Li TC, Makris M, Tomsu M, Tuckerman E, Laird S. Recurrent miscarriage: aetiology, management and prognosis. Hum. Reprod. Update. 2002;8:463–481
  45. Ludvigsson JF, Montgomery SM, Ekbom A. Celiac disease and risk of adverse fetal outcome: a population-based cohort study. Gastroenterology. 2005;129:454–463
  46. Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Lebel P, Dallongeville J, et al. A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans. Hum. Mol. Genet. 1998;7:435–440
  47. Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, et al. GM-CSF to reverse sepsis-associated immunosuppression: a double-blind randomized placebo-controlled multicenter trial. Am. J. Respir. Crit. Care Med. 2009;180(7):585–586
  48. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 2006;4:295–306
  49. Moffett A, Hiby S. Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages. Hum. Reprod. 2009;24:2048–2049
  50. Moffett A, Loke C. Immunology of placentation in eutherian mammals. Nat. Rev. Immunol. 2006;6:584–594
  51. Muy-Rivera M, Ning Y, Frederic IO, Vadachkoria S, Luthy DA, Williams MA. Leptin, soluble leptin receptor and leptin gene polymorphism in relation to preeclampsia risk. Physiol. Res. 2005;54:167–174
  52. Nonaka T, Takakuwa K, Ooki I, Akashi M, Yokoo T, Kikuchi A, et al. Results of immunotherapy for patients with unexplained primary recurrent abortions—prospective non-randomized cohort study. Am. J. Reprod. Immunol. 2007;58:530–536
  53. Pham T, Claudepierre P, Deprez X, Fautrel B, Goupille P, Hilliquin P, et al. Anti-TNF alpha therapy and safety monitoring. clinical tool guide elaborated by the Club Rhumatismes et Inflammations (CRI), section of the French Society of Rheumatology (Societe Francaise de Rhumatologie, SFR). Joint Bone Spine. 2005;72(1):S1–58
  54. Porcu G, Cravello L, D’ercole C, Cohen D, Roger V, De Montgolfier R, et al. Hysteroscopic metroplasty for septate uterus and repetitive abortions: reproductive outcome. Eur. J. Obstet. Gynecol. Reprod. Biol. 2000;88:81–84
  55. Rai R, Regan L. Recurrent miscarriage. Lancet. 2006;368:601–611
  56. Rai R, Tuddenham E, Backos M, Jivraj S, El’gaddal S, Choy S, et al. Thromboelastography, whole-blood haemostasis and recurrent miscarriage. Hum. Reprod. 2003;18:2540–2543
  57. Reimer T, Koczan D, Briese V, Friese K, Richter D, Thiesen HJ, et al. Absolute quantification of human chorionic gonadotropin-beta mRNA with TaqMan detection. 4. Mol. Biotechnol. 2000;14:47–57
  58. Roberts D, Schwartz RS. Clotting and hemorrhage in the placenta—a delicate balance. N. Engl. J. Med. 2002;347:57–59
  59. Rodger MA, Paidas M, Mclintock C, Middeldorp S, Kahn S, Martinelli I, et al. Inherited thrombophilia and pregnancy complications revisited. Obstet. Gynecol. 2008;112:320–324
  60. Salim R, Miel J, Savvas M, Lee C, Jurkovic D. A comparative study of glycodelin concentrations in uterine flushings in women with subseptate uteri, history of unexplained recurrent miscarriage and healthy controls. Eur. J. Obstet. Gynecol. Reprod. Biol. 2007;133:76–80
  61. Salim R, Regan L, Woelfer B, Backos M, Jurkovic D. A comparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent first trimester miscarriage. Hum. Reprod. 2003;18:162–166
  62. Scarpellini F, Sbracia M. Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Hum. Reprod. 2009;24(11):2703–2708Epub 2009 Jul 17
  63. Scholz C, Toth B, Brunnhuber R, Rampf E, Weissenbacher T, Santoso L, et al. Glycodelin A induces a tolerogenic phenotype in monocyte-derived dendritic cells in vitro. Am. J. Reprod. Immunol. 2008;60:501–512
  64. Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst. Rev. 2003;CD000112
  65. Stahn R, Goletz S, Stahn R, Wilmanowski R, Wang X, Briese V, et al. Human chorionic gonadotropin (hCG) as inhibitior of E-selectin-mediated cell adhesion. Anticancer Res. 2005;25:1811–1816
  66. Stern JJ, Dorfmann AD, Gutierrez-Najar AJ, Cerrillo M, Coulam CB. Frequency of abnormal karyotypes among abortuses from women with and without a history of recurrent spontaneous abortion. Fertil. Steril. 1996;65:250–253
  67. Stray-Pedersen B, Stray-Pedersen S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am. J. Obstet. Gynecol. 1984;148:140–146
  68. Stumvoll M, Haring H. The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism. Diabetes. 2002;51:2341–2347
  69. Sugimura M, Kobayashi T, Shu F, Kanayama N, Terao T. Annexin V inhibits phosphatidylserine-induced intrauterine growth restriction in mice. Placenta. 1999;20:555–560
  70. Sugiura-Ogasawara M, Furukawa TA, Nakano Y, Hori S, Aoki K, Kitamura T. Depression as a potential causal factor in subsequent miscarriage in recurrent spontaneous aborters. Hum. Reprod. 2002;17:2580–2584
  71. Tarrade A, Lai Kuen R, Malassine A, Tricottet V, Blain P, Vidaud M, et al. Characterization of human villous and extravillous trophoblasts isolated from first trimester placenta. Lab. Invest. 2001;81:1199–1211
  72. Toth B. Microparticles and female issues. Hamostaseologie. 2009;29:46–50
  73. Toth B, Bastug M, Mylonas I, Scholz C, Makovitzky J, Kunze S, et al. Peroxisome proliferator-activated receptor-gamma in normal human pregnancy and miscarriage. Acta Histochem. 2009;111(4):372–378Epub 2009 Apr 1
  74. Toth B, Bastug M, Mylonas I, Scholz C, Makovitzky J, Kunze S, et al. Peroxisome proliferator-activated receptor-gamma in normal human pregnancy and miscarriage. Acta Histochem. 2009;111:372–378
  75. Toth B, Bastug M, Scholz C, Arck P, Schulze S, Kunze S, et al. Leptin and peroxisome proliferator-activated receptors: impact on normal and disturbed first trimester human pregnancy. Histol. Histopathol. 2008;23:1465–1475
  76. Toth B, Hornung D, Scholz C, Djalali S, Friese K, Jeschke U. Peroxisome proliferator-activated receptors: new players in the field of reproduction. Am. J. Reprod. Immunol. 2007;58:289–310
  77. Toth B, Nieuwland R, Kern M, Rogenhofer N, Berkmans R, Rank A, et al. Systemic changes in haemostatic balance are not associated with increased levels of circulating microparticles in women with recurrent spontaneous abortion. Am. J. Reprod. Immunol. 2008;59:159–166
  78. Toth B, Roth K, Kunert-Keil C, Scholz C, Schulze S, Mylonas I, et al. Glycodelin protein and mRNA is downregulated in human first trimester abortion and partially upregulated in mole pregnancy. J. Histochem. Cytochem. 2008;56:477–485
  79. Tursi A, Giorgetti G, Brandimarte G, Elisei W. Effect of gluten-free diet on pregnancy outcome in celiac disease patients with recurrent miscarriages. Dig. Dis. Sci. 2008;53:2925–2928
  80. Van Den Heuvel MJ, Peralta CG, Hatta k, Han VK, Clark DA. Decline in number of elevated blood CD3(+) CD56(+) NKT cells in response to intravenous immunoglobulin treatment correlates with successful pregnancy. Am. J. Reprod. Immunol. 2007;58:447–459
  81. Vanwijk MJ, Vanbavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc. Res. 2003;59:277–287
  82. Whiteside TL. Cytokine measurements and interpretation of cytokine assays in human disease. J. Clin. Immunol. 1994;14:327–339
  83. Winger EE, Reed JL. Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion. Am. J. Reprod. Immunol. 2008;60:8–16
  84. Winger EE, Reed JL, Ashoush S, Ahuja S, El-Toukhy T, Taranissi M. Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF. Am. J. Reprod. Immunol. 2009;61:113–120
  85. Yang H, Qiu L, Di W, Zhao A, Chen G, Hu K, et al. Proportional change of CD4+ CD25+ regulatory T cells after lymphocyte therapy in unexplained recurrent spontaneous abortion patients. Fertil. Steril. 2009;92:301–305

PII: S0165-0378(10)00014-8

doi: 10.1016/j.jri.2009.12.006

Journal of Reproductive Immunology
Volume 85, Issue 1 , Pages 25-32 , May 2010

Article Tools

* Image Usage & Resolution